Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology von Naidoo, Jarushka, Murphy, Catherine, Atkins, Michael B, Brahmer, Julie R, Champiat, Stephane, Feltquate, David, Krug, Lee M, Moslehi, Javid, Pietanza, M Catherine, Riemer, Joanne, Robert, Caroline, Sharon, Elad, Suarez-Almazor, Maria E, Suresh, Karthik, Turner, Michelle, Weber, Jeffrey, Cappelli, Laura C

Volltext

Chronic immune checkpoint inhibitor pneumonitis von Naidoo, Jarushka, Cottrell, Tricia R, Lipson, Evan J, Forde, Patrick M, Illei, Peter B, Yarmus, Lonny B, Voong, K Ranh, Feller-Kopman, David, Lee, Hans, Riemer, Joanne, Wang, Daphne, Taube, Janis M, Brahmer, Julie R, Lin, Cheng Ting, Danoff, Sonye K, D'Alessio, Franco R, Suresh, Karthik

Volltext

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer von Rosner, Samuel, Reuss, Joshua E, Zahurak, Marianna, Zhang, Jiajia, Zeng, Zhen, Taube, Janis, Anagnostou, Valsamo, Smith, Kellie N, Riemer, Joanne, Illei, Peter B, Broderick, Stephen R, Jones, David R, Topalian, Suzanne L, Pardoll, Drew M, Brahmer, Julie R, Chaft, Jamie E, Forde, Patrick M

Volltext

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer von Rosner, Samuel, Reuss, Joshua E, Zahurak, Marianna, Zhang, Jiajia, Zeng, Zhen, Taube, Janis, Anagnostou, Valsamo, Smith, Kellie N, Riemer, Joanne, Illei, Peter B, Broderick, Stephen R, Jones, David R, Topalian, Suzanne L, Pardoll, Drew M, Brahmer, Julie R, Chaft, Jamie E, Forde, Patrick M

Volltext

Identifying strategies to address obstacles to optimal integration of cancer immunotherapies in the community von Shivakumar, Latha, Weldon, Christine B., McBride, Ali, Puzanov, Igor, Riemer, Joanne, Zibelman, Matthew R., Boehmer, Leigh

Volltext